Association between serum adiponectin, and pathological stage and grade in men undergoing radical prostatectomy

Journal of Urology

Volumn 174, Issue 4 I, 2005, Pages 1266-1270

  Freedland, Stephen J ^a   Sokoll, Lori J ^b   Platz, Elizabeth A ^b   Mangold, Leslie A ^b   Bruzek, Debra J ^b   Mohr, Phaedre ^b   Yiu, Sindy K ^b   Partin, Alan W ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b NONE

Author keywords

Adiponectin; Obesity; Prostate; Prostatectomy; Prostatic neoplasms

Indexed keywords

ADIPONECTIN; LEPTIN; PEPTIDE HORMONE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BODY MASS; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SERUM;

EID: 24944465001     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000173093.89897.97     Document Type: Article

References (21)

1. Flegal, K. M., Carroll, M. D., Ogden, C. L. and Johnson, C. L.: Prevalence and trends in obesity among US adults, 1999-2000. JAMA, 288: 1723, 2002
2. Rodriguez, C., Patel, A. V., Calle, E. E., Jacobs, E. J., Chao, A. and Thun, M. J.: Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev, 10: 345, 2001
3. Calle, E. E., Rodriguez, C., Walker-Thurmond, K. and Thun, M. J.: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med, 348: 1625, 2003
4. Snowdon, D. A., Phillips, R. L., and Choi, W.: Diet, obesity, and risk of fatal prostate cancer. Am J Epidemiol, 120: 244, 1984
5. Freedland, S. J., Aronson, W. J., Kane, C. J., Presti, J. C., Jr., Amling, C. L., Elashoff, D. et al: Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol, 22: 446, 2004
6. Amling, C. L., Riffenburgh, R. H., Sun, L., Moul, J. W., Lance, R. S., Kusuda, L. et al: Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol, 22: 439, 2004
7. Rohrmann, S., Roberts, W. W., Walsh, P. C. and Platz, E. A.: Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer. Prostate, 55: 140, 2003
8. Bray, G. A.: The underlying basis for obesity: relationship to cancer. J Nutr, 132: 3451S, 2002
9. Ribeiro, R., Lopes, C. and Medeiros, R.: Leptin and prostate: implications for cancer prevention-overview of genetics and molecular interactions. Eur J Cancer Prev, 13: 359, 2004
10. Yanovski, J. A. and Yanovski, S. Z.: Recent advances in basic obesity research. JAMA, 282: 1504, 1999
11. Onuma, M., Bub, J. D., Rummel, T. L. and Iwamoto, Y.: Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase. J Biol Chem, 278: 42660, 2003
12. Somasundar, P., Yu, A. K., Vona-Davis, L. and McFadden, D. W.: Differential effects of leptin on cancer in vitro. J Surg Res, 113: 50, 2003
13. Freedland, S. J., Sokoll, L. J., Mangold, L. A., Bruzek, D. J., Mohr, P., Yiu, S. K. et al: Serum leptin and pathological findings at the time of radical prostatectomy. J Urol, 173: 773, 2005
14. Haluzik, M., Parizkova, J. and Haluzik, M. M.: Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res, 53: 123, 2004
15. Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E. et al: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab, 86: 1930, 2001
16. Brakenhielm, E., Veitonmaki, N., Cao, R., Kihara, S., Matsuzawa, Y., Zhivotovsky, B. et al: Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA, 101: 2476, 2004
17. Dal Maso, L., Augustin, L. S., Karalis, A., Talamini, R., Franceschi, S., Trichopoulos, D. et al: Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab, 89: 1160, 2004
18. Mantzoros, C., Petridou, E., Dessypris, N., Chavelas, C., Dalamaga, M., Alexe, D. M. et al: Adiponectin and breast cancer risk. J Clin Endocrinol Metab, 89: 1102, 2004
19. Miyoshi, Y., Funahashi, T., Kihara, S., Taguchi, T., Tamaki, Y., Matsuzawa, Y. et al: Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res, 9: 5699, 2003.
20. Epstein, J. I., Pizov, G. and Walsh, P. C.: Correlation of pathollogic findings with progression after radical retropubic prostatectomy. Cancer, 71: 3582, 1993
21. Platz, E. A.: Energy imbalance and prostate cancer. J Nutr, 132: 3471S, 2002